- Inherited HLP2007 | Faculty of Physical Education and Sport
- Pharmacotherapy of HLP and DLP2010 | First Faculty of Medicine
- Combined treatment of HLP and DLP2005 | First Faculty of Medicine
- HLP and DLP in preventive cardiology2006 | First Faculty of Medicine
- HLP and DLP commbined treatment2007 | First Faculty of Medicine
- Treatment of HLP and DLP in diabetes2010 | First Faculty of Medicine
- Inherited HLP2007 | First Faculty of Medicine
- Aterosclerosis, HLP, DLP2006 | First Faculty of Medicine
- Complex treatment of HLP and DLP2007 | First Faculty of Medicine
- HLP and DLP as a risk factor of CVD2008 | First Faculty of Medicine
- HLP and DLP as a risk factor of CVD2008 | Publication without faculty affiliation
- Treatment of HLP and DLP in 20092009 | First Faculty of Medicine
- Pharmacotheraphy2005 | First Faculty of Medicine
- Why should a doctor be intersted in his hyperlipoproteinemic patient s smoking? Tobacco dependence treatment - short interventionPublication without faculty affiliation
- Kombinační léčba HLP/DLP 20182018 | First Faculty of Medicine
- Terapie hyperlipoproteinemií a dyslipidemií na začátku 20.let třetího milénia2021 | First Faculty of Medicine
- Hyperlipoproteinemias, atherosclerosis and cardiovascular diseases: Treatment of hyperlipidaemia Part II.2002 | First Faculty of Medicine
- Statins - rewiev2005 | First Faculty of Medicine
- What is the diference between whe treatment of DLP in primary and secondary prevention2005 | First Faculty of Medicine
- Dual inhibition - a new perspective2005 | First Faculty of Medicine
- Spirit of prof. Charvát with us2006 | First Faculty of Medicine
- Statin and fibrate in the treatment of DLP2006 | First Faculty of Medicine
- Atherosclerosis 20062006 | First Faculty of Medicine
- Target levels of LDL-C2006 | First Faculty of Medicine
- Atorva 80 in clinical practice2006 | First Faculty of Medicine
- 10 questions2006 | First Faculty of Medicine
- Ezetimibe2006 | First Faculty of Medicine
- Combination - the perspective of treatment of DLP2006 | First Faculty of Medicine
- Fenofibrate 250SR Pharmavit in patients with combined hyperlipidaemia2000 | First Faculty of Medicine
- Komentář k "Praktickému doporučení pro použití PCSK9-inhibitorů" aneb Proč renomovaní autoři píší dokumenty, které si samy odporují2018 | First Faculty of Medicine
